Endomyocardial biopsy in the diagnosis of cardiac sarcoidosis

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Ms Henriikka Malkonen

Helsinki University Hospital, Helsinki (Finland)

7 More presentations in this session

Presentation thumbnail

Mildly elevated left ventricular outflow tract gradients are associated with increased short term mortality in inpatients without septal hypertrophy

Doctor S. Khoury (Tel Aviv, IL)

Abstract Slides Video

Presentation thumbnail

Health-related quality of life disparity in cardiac sarcoidosis versus other myocardial diseases

Mrs J. Raak-Tarkiainen (Helsinki, FI)

Abstract Slides Video

Presentation thumbnail

Health-related quality of life and prognosis in cardiac sarcoidosis

Mrs J. Raak-Tarkiainen (Helsinki, FI)

Abstract Slides Video

Presentation thumbnail

Prevalence of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: the RETTRACE Study

Doctor D. Tsilakis (Athens, GR)

Abstract Slides Video

Presentation thumbnail

The role of 18fluorine-fluorodeoxyglucose positron emission tomography in the diagnosis, follow-up, and regulation of treatment in patients with cardiac sarcoidosis.

Doctor E. Bobbio (Gothenburg, SE)

Abstract Slides Video

Access the full session

Session thumbnail

Left ventricular hypertrophy and hypertrophic cardiomyopathy: new findings

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

Endomyocardial biopsy in patients with myocarditis - still justified in the CMR era? A single-centre experience

Congress Presentation

Detection of cardiac sarcoidosis with artificial intelligence-enhanced electrocardiography

Congress Presentation

Piecing together the puzzle: a cardiac sarcoidosis case

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources